Group Treatment | Inflammatory Foci | P value | Demyelination (LFB) | P value | Apoptotic Cells | P value |
---|---|---|---|---|---|---|
Preventative treatment regimen | ||||||
Naive | 0.0 ± 0.0 | <0.0001 | 0.0 ± 0.0 | <0.0001 | 0.0 ± 0.0 | <0.0001 |
Vehicle | 4.3 ± 3.2 | NA | 1.6 ± 1.0 | NA | 2.7 ± 2.5 | NA |
FTY720 (3 mg/kg) | 0.3 ± 1.0 | <0.0001 | 0.0 ± 0.2 | <0.0001 | 0.1 ± 0.4 | <0.0001 |
RVX-297 (75 mg/kg) | 1.5 ± 2.9 | 0.0004 | 0.1 ± 0.3 | <0.0001 | 0.5 ± 0.9 | <0.0001 |
RVX-297 (125 mg/kg) | 0.1 ± 0.6 | <0.0001 | 0.0 ± 0.0 | <0.0001 | 0.0 ± 0.0 | <0.0001 |
Therapeutic treatment regimen | ||||||
Naive | 0.0 ± 0.0 | <0.0001 | 0.0 ± 0.0 | <0.0001 | 0.0 ± 0.0 | <0.0001 |
Vehicle | 3.9 ± 2.4 | NA | 1.6 ± 0.8 | NA | 2.0 ± 1.8 | NA |
FTY720 (3 mg/kg) | 0.8 ± 0.9 | <0.0001 | 0.8 ± 0.5 | <0.0001 | 0.8 ± 0.9 | 0.002 |
RVX-297 (75 mg/kg) | 1.7 ± 1.2 | <0.0001 | 1.1 ± 0.8 | 0.02 | 0.5 ± 1.0 | 0.0002 |
RVX-297 (125 mg/kg) | 1.6 ± 1.9 | 0.0001 | 0.9 ± 0.8 | 0.002 | 0.3 ± 0.6 | <0.0001 |
LFB, Luxol fast blue; NA, not applicable.